The laser allows dental professionals to expand treatment offerings, including more same-day and multiquadrant dentistry, according to a Jan. 21 news release.
The patient experience is also improved, as patients have less discomfort and anxiety and fewer appointments.
Solea laser is the only CO2 laser that is FDA-approved for all tissue indications, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
